Michael Vasconcelles
CIK: 0001734755
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (13 total)
- Oct 30, 2026MGNX
MACROGENICS INC
Award(A)DirectStock Option (right to buy)
44K shares- - Oct 30, 2026MGNX
MACROGENICS INC
Award(A)DirectRestricted Stock Unit
7.5K shares- - Jun 4, 2026KURA
Kura Oncology, Inc.
Award(A)DirectOption to purchase common stock
35K shares- - Apr 23, 2026DAWN
Day One Biopharmaceuticals, Inc.
Disposition(D)Direct4.4K shares- - Feb 17, 2026DAWN
Day One Biopharmaceuticals, Inc.
Sale(S)Direct2.7K shares at avg. $11.60$32K - Feb 15, 2026DAWN
Day One Biopharmaceuticals, Inc.
Exercise(M)Direct7.1K shares- - Jan 30, 2026DAWN
Day One Biopharmaceuticals, Inc.
Award(A)DirectStock Option (right to buy Common Stock)
171K shares- - Jan 30, 2026DAWN
Day One Biopharmaceuticals, Inc.
Award(A)DirectRestricted Stock Units
114K shares- - Jun 16, 2025DAWN
Day One Biopharmaceuticals, Inc.
Award(A)DirectRestricted Stock Unit (RSU)
226K shares- - Jun 16, 2025DAWN
Day One Biopharmaceuticals, Inc.
Award(A)DirectStock Option (right to buy Common Stock)
346K shares- - Jun 5, 2025KURA
Kura Oncology, Inc.
Award(A)DirectOption to purchase common stock
28.5K shares- - Sep 13, 2024KURA
Kura Oncology, Inc.
Award(A)DirectOption to purchase common stock
17.3K shares- - Sep 13, 2024KURA
Kura Oncology, Inc.
Award(A)DirectOption to purchase common stock
52K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Oct 30, 2026 |  MGNX MACROGENICS INC | Award(A) Stock Option (right to buy) | 44,000 | - | - | Direct |
| Oct 30, 2026 | MGNX MACROGENICS INC | Award(A) Restricted Stock Unit | 7,500 | - | - | Direct |
| Jun 4, 2026 |  KURA Kura Oncology, Inc. | Award(A) Option to purchase common stock | 35,000 | - | - | Direct |
| Apr 23, 2026 |  DAWN Day One Biopharmaceuticals, Inc. | Disposition(D) | 4,397 | - | $0 | Direct |
| Feb 17, 2026 | DAWN Day One Biopharmaceuticals, Inc. | Sale(S) | 2,728 | $11.60 | $31,647 | Direct |
| Feb 15, 2026 | DAWN Day One Biopharmaceuticals, Inc. | Exercise(M) | 7,125 | - | $0 | Direct |
| Jan 30, 2026 | DAWN Day One Biopharmaceuticals, Inc. | Award(A) Stock Option (right to buy Common Stock) | 171,000 | - | - | Direct |
| Jan 30, 2026 | DAWN Day One Biopharmaceuticals, Inc. | Award(A) Restricted Stock Units | 114,000 | - | - | Direct |
| Jun 16, 2025 | DAWN Day One Biopharmaceuticals, Inc. | Award(A) Restricted Stock Unit (RSU) | 226,000 | - | - | Direct |
| Jun 16, 2025 | DAWN Day One Biopharmaceuticals, Inc. | Award(A) Stock Option (right to buy Common Stock) | 346,000 | - | - | Direct |
| Jun 5, 2025 | KURA Kura Oncology, Inc. | Award(A) Option to purchase common stock | 28,500 | - | - | Direct |
| Sep 13, 2024 | KURA Kura Oncology, Inc. | Award(A) Option to purchase common stock | 17,333 | - | - | Direct |
| Sep 13, 2024 | KURA Kura Oncology, Inc. | Award(A) Option to purchase common stock | 52,000 | - | - | Direct |
1-13 of 13 transactions
About VASCONCELLES MICHAEL
VASCONCELLES MICHAEL (SEC CIK 0001734755) files insider reports with the SEC as Director of MACROGENICS INC (MGNX), Director of Kura Oncology, Inc. (KURA) and Head of Research and Dev. of Day One Biopharmaceuticals, Inc. (DAWN).
Signal8 holds 11 ownership filings by VASCONCELLES MICHAEL (3 Form 3, 8 Form 4), filed between Sep 17, 2024 and Nov 3, 2026. Those filings report 13 transactions, from Sep 13, 2024 to Oct 30, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on VASCONCELLES MICHAEL's filings is in ROCKVILLE, MD.
Recent filings by VASCONCELLES MICHAEL
- Oct 30, 2026: Grants or awards of MGNX derivative securities (2 lines, Form 4, code A).
- Jun 4, 2026: Grant or award of KURA derivative securities (Form 4, code A).
- Apr 23, 2026: Disposition to issuer transaction of DAWN shares (Form 4, code D).
- Feb 17, 2026: Open-market sale of DAWN shares (Form 4, code S).
- Feb 15, 2026: Option exercise of DAWN shares (Form 4, code M).
Other insiders filing for MACROGENICS INC (MGNX)
- Kuriakose Emil, Director
- Bonvini Ezio, Sr VP, Research & CSO
- Peters Jeffrey Stuart, Senior VP, GC, and Secretary
- O'Brien Federica F., Director
- Jackson Scott Thomas, Director
- HEIDEN WILLIAM K, Director